Citations (153)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (22)
Bingting Li, Jun Zhang, Ning Ma, Weidan Li, Guoxing You, Gan Chen, Lian Zhao, Quan Wang & Hong Zhou. (2023) PEG-conjugated bovine haemoglobin enhances efficiency of chemotherapeutic agent doxorubicin with alleviating DOX-induced splenocardiac toxicity in the breast cancer. Artificial Cells, Nanomedicine, and Biotechnology 51:1, pages 120-130.
Read now
Read now
Koilpillai Jebastin & Damodharan Narayanasamy. (2023) Rationale utilization of phospholipid excipients: a distinctive tool for progressing state of the art in research of emerging drug carriers. Journal of Liposome Research 33:1, pages 1-33.
Read now
Read now
Neha Bansal, Chaitya Joshi, Michael Jacob Adams, Kelley Hutchins, Andrew Ray & Steven E. Lipshultz. (2021) Cardiotoxicity in pediatric lymphoma survivors. Expert Review of Cardiovascular Therapy 19:11, pages 957-974.
Read now
Read now
Alina Sesarman, Dana Muntean, Bianca Abrudan, Lucia Tefas, Bianca Sylvester, Emilia Licarete, Valentin Rauca, Lavinia Luput, Laura Patras, Manuela Banciu, Laurian Vlase & Alina Porfire. (2021) Improved pharmacokinetics and reduced side effects of doxorubicin therapy by liposomal co-encapsulation with curcumin. Journal of Liposome Research 31:1, pages 1-10.
Read now
Read now
Kamel S. Ahmed, Sun Changling, Xiaotian Shan, Jing Mao, Lipeng Qiu & Jinghua Chen. (2020) Liposome-based codelivery of celecoxib and doxorubicin hydrochloride as a synergistic dual-drug delivery system for enhancing the anticancer effect. Journal of Liposome Research 30:3, pages 285-296.
Read now
Read now
Ummarah Kanwal, Nadeem Irfan Bukhari, Muhammad Ovais, Nasir Abass, Khalid Hussain & Abida Raza. (2018) Advances in nano-delivery systems for doxorubicin: an updated insight. Journal of Drug Targeting 26:4, pages 296-310.
Read now
Read now
Gaurav Sharma, Kanwaljit Chopra, Sanjeev Puri, Mahendra Bishnoi, Praveen Rishi & Indu P. Kaur. (2018) Topical delivery of TRPsiRNA-loaded solid lipid nanoparticles confer reduced pain sensation via TRPV1 silencing, in rats. Journal of Drug Targeting 26:2, pages 135-149.
Read now
Read now
Fang Li, Chunli Zheng, Junbo Xin, Fangcheng Chen, Hua Ling, Linlin Sun, Thomas J Webster, Xin Ming & Jianping Liu. (2016) Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base. International Journal of Nanomedicine 11, pages 3875-3890.
Read now
Read now
Smita Pawar, Ganesh Shevalkar & Pradeep Vavia. (2016) Glucosamine-anchored doxorubicin-loaded targeted nano-niosomes: pharmacokinetic, toxicity and pharmacodynamic evaluation. Journal of Drug Targeting 24:8, pages 730-743.
Read now
Read now
Victoria Leonhard, Roxana V Alasino, Ismael D Bianco, Ariel G Garro, Valeria Heredia & Dante M Beltramo. (2015) Biochemical characterization of the interactions between doxorubicin and lipidic GM1 micelles with or without paclitaxel loading. International Journal of Nanomedicine 10, pages 3377-3388.
Read now
Read now
Antonella Accardo, Giuseppina Salsano, Anna Morisco, Michela Aurilio, Antonio Parisi, Francesco Maione, Carla Cicala, Diego Tesauro, Luigi Aloj, Giuseppe De Rosa & Giancarlo Morelli. (2012) Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent. International Journal of Nanomedicine 7, pages 2007-2017.
Read now
Read now
Masayuki Yokoyama. (2010) Polymeric micelles as a new drug carrier system and their required considerations for clinical trials. Expert Opinion on Drug Delivery 7:2, pages 145-158.
Read now
Read now
Yi Shi, William Porter, Thomas Merdan & Luk Chiu Li. (2009) Recent advances in intravenous delivery of poorly water-soluble compounds. Expert Opinion on Drug Delivery 6:12, pages 1261-1282.
Read now
Read now
A. Ruggiero, V. Ridola, N. Puma, F. Molinari, P. Coccia, G. De Rosa & R. Riccardi. (2008) ANTHRACYCLINE CARDIOTOXICITY IN CHILDHOOD. Pediatric Hematology and Oncology 25:4, pages 261-281.
Read now
Read now
Qing Chen, Ava Krol, Alex Wright, David Needham, Mark W. Dewhirst & Fan Yuan. (2008) Tumor microvascular permeability is a key determinant for antivascular effects of doxorubicin encapsulated in a temperature sensitive liposome. International Journal of Hyperthermia 24:6, pages 475-482.
Read now
Read now
Atiar M Rahman, Syed Wamique Yusuf & Michael S Ewer. (2007) Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation. International Journal of Nanomedicine 2:4, pages 567-583.
Read now
Read now
Vijay I Kulkarni, Vikram S Shenoy, Shamsunder S Dodiya, Tushar H Rajyaguru & Rayasa R Murthy. (2006) Role of calcium in gene delivery. Expert Opinion on Drug Delivery 3:2, pages 235-245.
Read now
Read now
Sérgio Simões, Ana Filipe, Henrique Faneca, Miguel Mano, Nuno Penacho, Nejat Düzgünes & Maria Pedroso de Lima. (2005) Cationic liposomes for gene delivery. Expert Opinion on Drug Delivery 2:2, pages 237-254.
Read now
Read now
Gerald Batist, Jeremy Barton, Philip Chaikin, Christine Swenson & Lauri Welles. (2002) Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy. Expert Opinion on Pharmacotherapy 3:12, pages 1739-1751.
Read now
Read now
Wenjin Guo, Tina Lee, Jennifer Sudimack & Robert J. Lee. (2000) Receptor-Specific Delivery of Liposomes Via Folate-Peg-Chol. Journal of Liposome Research 10:2-3, pages 179-195.
Read now
Read now
M. Yokoyama, T. Okano, Y. Sakurai, S. Fukushima, K. Okamoto & K. Kataoka. (1999) Selective Delivery of Adiramycin to a Solid Tumor Using a Polymeric Micelle Carrier System. Journal of Drug Targeting 7:3, pages 171-186.
Read now
Read now
Toshiyuki Sakaeda, Hisato Kakushi, Tsutomu Shike, Kyoji Takano, Toshio Harauchi, Masaharu Hirata & Koichiro Hirano. (1998) O/W Lipid Emulsions for Parenteral Drug Delivery. IV. Changes in the Pharmacokinetics and Pharmacodynamics of a Highly Lipophilic Drug, Menatetrenone. Journal of Drug Targeting 6:3, pages 183-189.
Read now
Read now
Articles from other publishers (131)
Jiaming Xu, Vyshnavi Karra, Danielle E. Large, Debra T. Auguste & Francisco R. Hung. (2023) Understanding the Mechanical Properties of Ultradeformable Liposomes Using Molecular Dynamics Simulations. The Journal of Physical Chemistry B 127:44, pages 9496-9512.
Crossref
Crossref
Pratikshya Sa, Priyanka Mohapatra, Shasank Sekhar Swain, Auromira Khuntia & Sanjeeb Kumar Sahoo. (2023) Phytochemical-Based Nanomedicine for Targeting Tumor Microenvironment and Inhibiting Cancer Chemoresistance: Recent Advances and Pharmacological Insights. Molecular Pharmaceutics 20:11, pages 5254-5277.
Crossref
Crossref
Yizhu Li, Yurong Ling, Morten O. Loehr, Sabrina Chaabane, Oh Wan Cheng, Kaifeng Zhao, Chao Wu, Moritz Büscher, Jana Weber, Daria Stomakhine, Marina Munker, Ronja Pientka, Sarah B. Christ, Matthias Dobbelstein & Nathan W. Luedtke. (2023) DNA templated Click Chemistry via 5-vinyl-2′-deoxyuridine and an acridine-tetrazine conjugate induces DNA damage and apoptosis in cancer cells. Life Sciences 330, pages 122000.
Crossref
Crossref
Diego Salas Sanzana, Emilia Flores Faúndez, Jaime Meléndez & Marco Soto-Arriaza. (2023) Increased delivery and cytotoxicity of doxorubicin in HeLa cells using the synthetic cationic peptide pEM-2 functionalized liposomes. Colloids and Surfaces B: Biointerfaces 228, pages 113420.
Crossref
Crossref
Nan Li, Ying-Xia Xiong, Fan Ye, Bing Jin, Jin-Jia Wu, Miao-Miao Han, Tian Liu, Yi-Kai Fan, Cun-Yu Li, Jiu-Shi Liu, Ying-Hua Zhang, Gui-Bo Sun, Yun Zhang & Zheng-Qi Dong. (2023) Isolation, Purification, and Structural Characterization of Polysaccharides from Codonopsis pilosula and Their Anti-Tumor Bioactivity by Immunomodulation. Pharmaceuticals 16:6, pages 895.
Crossref
Crossref
Pooya Faranoush, Alireza Jahandideh, Reza Nekouian & Pejman Mortazavi. (2023) Evaluation of the in vitro and in vivo effect of liposomal doxorubicin along with oncolytic Newcastle disease virus on 4T1 cell line: Animal preclinical research. Veterinary Medicine and Science 9:3, pages 1426-1437.
Crossref
Crossref
Melody D. Fulton & Wided Najahi-Missaoui. (2023) Liposomes in Cancer Therapy: How Did We Start and Where Are We Now. International Journal of Molecular Sciences 24:7, pages 6615.
Crossref
Crossref
Svetlana V. Kurmaz, Irina I. Ivanova, Nina S. Emelyanova, Dmitry V. Konev, Vladimir A. Kurmaz, Natalia V. Filatova, Anastasia A. Balakina & Alexei A. Terentiev. (2023) Doxorubicin compositions with biocompatible terpolymer of N-vinylpyrrolidone, methacrylic acid and triethylene glycol dimethacrylate. Mendeleev Communications 33:2, pages 255-258.
Crossref
Crossref
Edyta Maroń, Paweł Krysiński & Michał Chudy. 2023. Liposomes - Recent Advances, New Perspectives and Applications. Liposomes - Recent Advances, New Perspectives and Applications.
Sana Ijaz, Misbah Sultana, Rahat Shamim & Nadeem Irfan Bukhari. (2023) Development and DoE-ANN based optimization of novel swellable matrix-diffusible doxorubicin loaded zinc oxide nanoflowers using sonochemical-precipitation method. International Journal of Pharmaceutics 633, pages 122584.
Crossref
Crossref
Lalit Kumar, Shivani Verma, Kajal Joshi & Sumit Sharma. (2023) Exploring the Therapeutic Potential of Anticancer Heterocyclic Compounds: Role in Nanoscale Pharmacotherapy. Critical Reviews™ in Therapeutic Drug Carrier Systems 40:3, pages 47-94.
Crossref
Crossref
Cristina Wöhlke Vendruscolo, Beatriz Ewert de Oliveira & Gislaine Ricci Leonardi. 2023. Biotechnology Applied to Inflammatory Diseases. Biotechnology Applied to Inflammatory Diseases
305
322
.
Jian Chen. 2023. Liposomes. Liposomes
95
101
.
Anita Barzegar-Fallah, Kushan Gandhi, Shakila B. Rizwan, Tania L. Slatter & John N. J. Reynolds. (2022) Harnessing Ultrasound for Targeting Drug Delivery to the Brain and Breaching the Blood–Brain Tumour Barrier. Pharmaceutics 14:10, pages 2231.
Crossref
Crossref
Alexander A. Artyukhov, Anna M. Nechaeva, Mikhail I. Shtilman, Evgeniy M. Chistyakov, Alina Yu. Svistunova, Dmitry V. Bagrov, Andrey N. Kuskov, Anca O. Docea, Aristides M. Tsatsakis, Leonid Gurevich & Yaroslav O. Mezhuev. (2022) Nanoaggregates of Biphilic Carboxyl-Containing Copolymers as Carriers for Ionically Bound Doxorubicin. Materials 15:20, pages 7136.
Crossref
Crossref
E. R. Gomes, A. T. Carvalho, T. C. Barbosa, L. L. Ferreira, H. D. R. Calado, A. P. Sabino & M. C. Oliveira. (2022) Fusion of Tumor-Derived Exosomes with Long-Circulating and pH-Sensitive Liposomes Loaded with Doxorubicin for the Treatment of Breast Cancer. AAPS PharmSciTech 23:7.
Crossref
Crossref
Anjan Motamarry, A. Marissa Wolfe, Krishna K. Ramajayam, Sanket Pattanaik, Thomas Benton, Yuri Peterson, Pegah Faridi, Punit Prakash, Katherine Twombley & Dieter Haemmerich. (2022) Extracorporeal Removal of Thermosensitive Liposomal Doxorubicin from Systemic Circulation after Tumor Delivery to Reduce Toxicities. Cancers 14:5, pages 1322.
Crossref
Crossref
Shirleide Santos Nunes, Juliana de Oliveira Silva, Renata Salgado Fernandes, Sued Eustaquio Mendes Miranda, Elaine Amaral Leite, Marcelo Alexandre de Farias, Rodrigo Villares Portugal, Geovanni Dantas Cassali, Danyelle M. Townsend, Mônica Cristina Oliveira & André Luís Branco de Barros. (2022) PEGylated versus Non-PEGylated pH-Sensitive Liposomes: New Insights from a Comparative Antitumor Activity Study. Pharmaceutics 14:2, pages 272.
Crossref
Crossref
William L. Odette, Christopher D. Hennecker, Anthony K. Mittermaier & Janine Mauzeroll. (2021) EDTA-Gradient Loading of Doxorubicin into Ferrocene-Containing Liposomes: Effect of Lipid Composition and Visualization of Triggered Release by Cryo-TEM. Langmuir 37:38, pages 11222-11232.
Crossref
Crossref
Claire Fraley, Sarah A. Milgrom, Lavanya Kondapalli, Matthew R. G. Taylor, Luisa Mestroni & Shelley D. Miyamoto. (2021) Mechanisms and Insights for the Development of Heart Failure Associated with Cancer Therapy. Children 8:9, pages 829.
Crossref
Crossref
Meriem El Founi, Hamed Laroui, Brandon S.B. Canup, Joseph S. Ametepe, Régis Vanderesse, Samir Acherar, Jérome Babin, Khalid Ferji, Isabelle Chevalot & Jean-Luc Six. (2021)
Doxorubicin Intracellular Release
Via
External UV Irradiation of Dextran-
g
-poly(
o
-nitrobenzyl acrylate) Photosensitive Nanoparticles
. ACS Applied Bio Materials 4:3, pages 2742-2751.
Crossref
Crossref
Anita Barzegar-fallah, Josh Houlton, Deanna Barwick, Amin Shavandi, M. Azam Ali, Andrew N. Clarkson & Houman Alimoradi. 2021. Theory and Applications of Nonparenteral Nanomedicines. Theory and Applications of Nonparenteral Nanomedicines
467
487
.
Manish Vyas, Daniel A. Simbo, Mohd. Mursalin, Vijay Mishra, Roqia Bashary & Gopal L. Khatik. (2020) Drug Delivery Approaches for Doxorubicin in the Management of Cancers. Current Cancer Therapy Reviews 16:4, pages 320-331.
Crossref
Crossref
Xiangsheng Liu, Ivanna Tang, Zev A. Wainberg & Huan Meng. (2020) Safety Considerations of Cancer Nanomedicine—A Key Step toward Translation. Small 16:36, pages 2000673.
Crossref
Crossref
Stefania Boi, Nadia Rouatbi, Elena Dellacasa, Donatella Di Lisa, Paolo Bianchini, Orietta Monticelli & Laura Pastorino. (2020) Alginate microbeads with internal microvoids for the sustained release of drugs. International Journal of Biological Macromolecules 156, pages 454-461.
Crossref
Crossref
Verena Schwach, Rolf H. Slaats & Robert Passier. (2020) Human Pluripotent Stem Cell-Derived Cardiomyocytes for Assessment of Anticancer Drug-Induced Cardiotoxicity. Frontiers in Cardiovascular Medicine 7.
Crossref
Crossref
Wei Chung Sim, Nuttanun Kutrakul, Panida Khunkaewla & Albert Schulte. (2020) Three-Electrode 30–60 μL Mini-Cell for Ecologically Conscious Analytical Voltammetry with Common Macro- and Microelectrodes. ACS Sustainable Chemistry & Engineering 8:13, pages 5082-5090.
Crossref
Crossref
Ayaka Ishihara, Shuji Hatakeyama, Jun Suzuki, Yusuke Amano, Teppei Sasahara, Masaki Toshima & Yuji Morisawa. (2019) Histological evidence for the cardiac safety of high-dose pegylated liposomal doxorubicin in a patient with HIV-associated Kaposi sarcoma: a case report and literature review. BMC Infectious Diseases 19:1.
Crossref
Crossref
Asmita Das, Pangwan M. Konyak, Argha Das, Subrata Kumar Dey & Chabita Saha. (2019) Physicochemical characterization of dual action liposomal formulations: anticancer and antimicrobial. Heliyon 5:8, pages e02372.
Crossref
Crossref
Thankaraj Salammal Sheena, Perumalsamy Balaji, Rajiu Venkatesan, Mohammad Abdulkader Akbarsha & K. Jeganathan. (2018) Functional evaluation of doxorubicin decorated polymeric liposomal curcumin: a surface tailored therapeutic platform for combination chemotherapy. New Journal of Chemistry 42:20, pages 16608-16619.
Crossref
Crossref
Yong Sze Ong, Latifah Saiful Yazan, Wei Keat Ng, Rasedee Abdullah, Noordin M Mustapha, Sarah Sapuan, Jhi Biau Foo, Yin Sim Tor, Chee Wun How, Napsiah Abd Rahman & Fatin Hannani Zakarial Ansar. (2018) Thymoquinone loaded in nanostructured lipid carrier showed enhanced anticancer activity in 4T1 tumor-bearing mice. Nanomedicine 13:13, pages 1567-1582.
Crossref
Crossref
Monika Długosz-Danecka, Alicja M. Gruszka, Sebastian Szmit, Agnieszka Olszanecka, Tomasz Ogórka, Marcin Sobociński, Andrzej Jaroszyński, Katarzyna Krawczyk, Aleksander B. Skotnicki & Wojciech Jurczak. (2018) Primary Cardioprotection Reduces Mortality in Lymphoma Patients with Increased Risk of Anthracycline Cardiotoxicity, Treated by R-CHOP Regimen. Chemotherapy 63:4, pages 238-245.
Crossref
Crossref
Hindumathi R. Dhanasekaran, Chandra Prakash Sharma & Prathap Haridoss. 2018. Drug Delivery Nanosystems for Biomedical Applications. Drug Delivery Nanosystems for Biomedical Applications
1
12
.
David Cipolla. 2016. Advances in Pulmonary Drug Delivery. Advances in Pulmonary Drug Delivery
151
174
.
Renata S. Fernandes, Juliana O. Silva, Liziane O.F. Monteiro, Elaine A. Leite, Geovanni D. Cassali, Domenico Rubello, Valbert N. Cardoso, Lucas A.M. Ferreira, Mônica C. Oliveira & André L.B. de Barros. (2016) Doxorubicin-loaded nanocarriers: A comparative study of liposome and nanostructured lipid carrier as alternatives for cancer therapy. Biomedicine & Pharmacotherapy 84, pages 252-257.
Crossref
Crossref
Jyothsna Akam-Venkata, Vivian I. Franco & Steven E. Lipshultz. (2016) Late Cardiotoxicity: Issues for Childhood Cancer Survivors. Current Treatment Options in Cardiovascular Medicine 18:7.
Crossref
Crossref
Pier P. Bassareo, Ines Monte, Claudia Romano, Martino Deidda, Alessandra Piras, Lucia Cugusi, Carmela Coppola, Francesca Galletta & Giuseppe Mercuro. (2016) Cardiotoxicity from anthracycline and cardioprotection in paediatric cancer patients. Journal of Cardiovascular Medicine 17, pages e55-e63.
Crossref
Crossref
Kathryn M. Camacho, Stefano Menegatti, Douglas R. Vogus, Anusha Pusuluri, Zoë Fuchs, Maria Jarvis, Michael Zakrewsky, Michael A. Evans, Renwei Chen & Samir Mitragotri. (2016) DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy. Journal of Controlled Release 229, pages 154-162.
Crossref
Crossref
Emiliana Perillo, Stefania Porto, Annarita Falanga, Silvia Zappavigna, Paola Stiuso, Virginia Tirino, Vincenzo Desiderio, Gianpaolo Papaccio, Massimiliano Galdiero, Antonio Giordano, Stefania Galdiero & Michele Caraglia. (2015) Liposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines. Oncotarget 7:4, pages 4077-4092.
Crossref
Crossref
Ahmad Jiblaoui, Julie Barbeau, Thomas Vivès, Patrick Cormier, Virginie Glippa, Bertrand Cosson & Thierry Benvegnu. (2016) Folate-conjugated stealth archaeosomes for the targeted delivery of novel antitumoral peptides. RSC Advances 6:79, pages 75234-75241.
Crossref
Crossref
Rahi M. Reja, Mohsina Khan, Sumeet K. Singh, Rajkumar Misra, Anjali Shiras & Hosahudya N. Gopi. (2016) pH sensitive coiled coils: a strategy for enhanced liposomal drug delivery. Nanoscale 8:9, pages 5139-5145.
Crossref
Crossref
Shahnawaz M. Amdani, Neha Bansal, Vivian I. Franco, Michael Jacob Adams & Steven E. Lipshultz. 2016. Clinical Cardio-Oncology. Clinical Cardio-Oncology
397
431
.
Ashay Jain, Prashant Kesharwani, Neeraj K. Garg, Atul Jain, Som Akshay Jain, Amit Kumar Jain, Pradip Nirbhavane, Raksha Ghanghoria, Rajeev Kumar Tyagi & Om Prakash Katare. (2015) Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin. Colloids and Surfaces B: Biointerfaces 134, pages 47-58.
Crossref
Crossref
Sarah Rohlfing, Matthias Aurich, Tilman Schöning, Anthony D. Ho & Mathias Witzens-Harig. (2015) Nonpegylated Liposomal Doxorubicin as a Component of R-CHOP Is an Effective and Safe Alternative to Conventional Doxorubicin in the Treatment of Patients With Diffuse Large B-Cell Lymphoma and Preexisting Cardiac Diseases. Clinical Lymphoma Myeloma and Leukemia 15:8, pages 458-463.
Crossref
Crossref
Emiliana Perillo, Emilie Allard-Vannier, Annarita Falanga, Paola Stiuso, Maria Teresa Vitiello, Massimiliano Galdiero, Stefania Galdiero & Igor Chourpa. (2015) Quantitative and qualitative effect of gH625 on the nanoliposome-mediated delivery of mitoxantrone anticancer drug to HeLa cells. International Journal of Pharmaceutics 488:1-2, pages 59-66.
Crossref
Crossref
Serge Mignani, Maria Bryszewska, Barbara Klajnert-Maculewicz, Maria Zablocka & Jean-Pierre Majoral. (2014) Advances in Combination Therapies Based on Nanoparticles for Efficacious Cancer Treatment: An Analytical Report. Biomacromolecules 16:1, pages 1-27.
Crossref
Crossref
Hernan Carol, Mannie M. Y. Fan, Troy O. Harasym, Ingrid Boehm, Lawrence D. Mayer, Peter Houghton, Malcolm A. Smith & Richard B. Lock. (2015) Efficacy of CPX-351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing Program. Pediatric Blood & Cancer 62:1, pages 65-71.
Crossref
Crossref
Jaromir Gumulec, Michaela Fojtu, Martina Raudenska, Marketa Sztalmachova, Anna Skotakova, Jana Vlachova, Sylvie Skalickova, Lukas Nejdl, Pavel Kopel, Lucia Knopfova, Vojtech Adam, Rene Kizek, Marie Stiborova, Petr Babula & Michal Masarik. (2014) Modulation of Induced Cytotoxicity of Doxorubicin by Using Apoferritin and Liposomal Cages. International Journal of Molecular Sciences 15:12, pages 22960-22977.
Crossref
Crossref
V. LORUSSO, F. GIOTTA, R. BORDONARO, E. MAIELLO, S. DEL PRETE, V. GEBBIA, G. FILIPELLI, S. PISCONTI, S. CINIERI, S. ROMITO, F. RICCARDI, R. FORCIGNANÒ, M. CICCARESE, L. PETRUCELLI, V. SARACINO, L.I. LUPO, A. GAMBINO, S. LEO & G. COLUCCI. (2014) Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy: A multicenter phase III study. International Journal of Oncology 45:5, pages 2137-2142.
Crossref
Crossref
Pieter J. Gaillard, Chantal C. M. Appeldoorn, Rick Dorland, Joan van Kregten, Francesca Manca, Danielle J. Vugts, Bert Windhorst, Guus A. M. S. van Dongen, Helga E. de Vries, David Maussang & Olaf van Tellingen. (2014) Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101). PLoS ONE 9:1, pages e82331.
Crossref
Crossref
Shoji Tachikawa, Tatsuro Miyoshi, Hayato Koganei, Mohamed E. El-Zaria, Clara Viñas, Minoru Suzuki, Koji Ono & Hiroyuki Nakamura. (2014)
Spermidinium
closo
-dodecaborate-encapsulating liposomes as efficient boron delivery vehicles for neutron capture therapy
. Chem. Commun. 50:82, pages 12325-12328.
Crossref
Crossref
Steven E. Lipshultz, M. Jacob Adams, Steven D. Colan, Louis S. Constine, Eugene H. Herman, Daphne T. Hsu, Melissa M. Hudson, Leontien C. Kremer, David C. Landy, Tracie L. Miller, Kevin C. Oeffinger, David N. Rosenthal, Craig A. Sable, Stephen E. Sallan, Gautam K. Singh, Julia Steinberger, Thomas R. Cochran & James D. Wilkinson. (2013) Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions. Circulation 128:17, pages 1927-1995.
Crossref
Crossref
Serge Mignani, Saïd El Kazzouli, Mosto Bousmina & Jean-Pierre Majoral. (2013) Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: A concise overview. Advanced Drug Delivery Reviews 65:10, pages 1316-1330.
Crossref
Crossref
David Needham & Mark W. Dewhirst. 2013. Smart Materials for Drug Delivery. Smart Materials for Drug Delivery
33
79
.
Hiroyuki Nakamura. (2013) Boron lipid-based liposomal boron delivery system for neutron capture therapy: recent development and future perspective. Future Medicinal Chemistry 5:6, pages 715-730.
Crossref
Crossref
Antonella Accardo, Gaetano Mangiapia, Luigi Paduano, Giancarlo Morelli & Diego Tesauro. (2013) Octreotide labeled aggregates containing platinum complexes as nanovectors for drug delivery. Journal of Peptide Science 19:4, pages 190-197.
Crossref
Crossref
Xavier Mulet, Ben J. Boyd & Calum J. Drummond. (2013) Advances in drug delivery and medical imaging using colloidal lyotropic liquid crystalline dispersions. Journal of Colloid and Interface Science 393, pages 1-20.
Crossref
Crossref
Hayato Koganei, Manabu Ueno, Shoji Tachikawa, Lisa Tasaki, Hyun Seung Ban, Minoru Suzuki, Kouichi Shiraishi, Kumi Kawano, Masayuki Yokoyama, Yoshie Maitani, Koji Ono & Hiroyuki Nakamura. (2012) Development of High Boron Content Liposomes and Their Promising Antitumor Effect for Neutron Capture Therapy of Cancers. Bioconjugate Chemistry 24:1, pages 124-132.
Crossref
Crossref
Serge Mignani & Jean-Pierre Majoral. (2013) Dendrimers as macromolecular tools to tackle from colon to brain tumor types: a concise overview. New Journal of Chemistry 37:11, pages 3337.
Crossref
Crossref
Melis Sardan, Murat Kilinc, Rukan Genc, Ayse B. Tekinay & Mustafa O. Guler. (2013) Cell penetrating peptide amphiphile integrated liposomal systems for enhanced delivery of anticancer drugs to tumor cells. Faraday Discussions 166, pages 269.
Crossref
Crossref
Naozumi Ohnishi, Eiichi Yamamoto, Hiromasa Tomida, Kenji Hyodo, Hiroshi Ishihara, Hiroshi Kikuchi, Kohei Tahara & Hirofumi Takeuchi. (2013) Rapid determination of the encapsulation efficiency of a liposome formulation using column-switching HPLC. International Journal of Pharmaceutics 441:1-2, pages 67-74.
Crossref
Crossref
S. Kansal, R. Tandon, P. Dwivedi, P. Misra, P. R. P. Verma, A. Dube & P. R. Mishra. (2012) Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis. Journal of Antimicrobial Chemotherapy 67:11, pages 2650-2660.
Crossref
Crossref
Anil Kumar ShuklaSanjukta PatraVikash Kumar Dubey. (2012) Nanospheres Encapsulating Anti-Leishmanial Drugs for Their Specific Macrophage Targeting, Reduced Toxicity, and Deliberate Intracellular Release. Vector-Borne and Zoonotic Diseases 12:11, pages 953-960.
Crossref
Crossref
Morten B. Hansen, Ethlinn van Gaal, Inge Minten, Gert Storm, Jan C.M. van Hest & Dennis W.P.M. Löwik. (2012) Constrained and UV-activatable cell-penetrating peptides for intracellular delivery of liposomes. Journal of Controlled Release 164:1, pages 87-94.
Crossref
Crossref
Peng Guo, Jin-Oh You, Jiang Yang, Marsha A. Moses & Debra T. Auguste. (2012) Using breast cancer cell CXCR4 surface expression to predict liposome binding and cytotoxicity. Biomaterials 33:32, pages 8104-8110.
Crossref
Crossref
Zahraa S. Al-Ahmady, Wafa’ T. Al-Jamal, Jeroen V. Bossche, Tam T. Bui, Alex F. Drake, A. James Mason & Kostas Kostarelos. (2012)
Lipid–Peptide Vesicle Nanoscale Hybrids for Triggered Drug Release by Mild Hyperthermia
in Vitro
and
in Vivo
. ACS Nano 6:10, pages 9335-9346.
Crossref
Crossref
Wenbing Dai, Tingyuan Yang, Yiguang Wang, Xueqing Wang, Jiancheng Wang, Xuan Zhang & Qiang Zhang. (2012) Peptide PHSCNK as an integrin α5β1 antagonist targets stealth liposomes to integrin-overexpressing melanoma. Nanomedicine: Nanotechnology, Biology and Medicine 8:7, pages 1152-1161.
Crossref
Crossref
Danielle Harake, Vivian I Franco, Jacqueline M Henkel, Tracie L Miller & Steven E Lipshultz. (2012) Cardiotoxicity in childhood cancer survivors: strategies for prevention and management. Future Cardiology 8:4, pages 647-670.
Crossref
Crossref
Lisa M. Kaminskas, Victoria M. McLeod, Brian D. Kelly, Gian Sberna, Ben J. Boyd, Mark Williamson, David J. Owen & Christopher J.H. Porter. (2012) A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems. Nanomedicine: Nanotechnology, Biology and Medicine 8:1, pages 103-111.
Crossref
Crossref
Rossella Tarallo, Antonella Accardo, Annarita Falanga, Daniela Guarnieri, Giuseppe Vitiello, Paolo Netti, Gerardino D'Errico, Giancarlo Morelli & Stefania Galdiero. (2011)
Clickable Functionalization of Liposomes with the gH625 Peptide from
Herpes simplex
Virus Type I for Intracellular Drug Delivery
. Chemistry – A European Journal 17:45, pages 12659-12668.
Crossref
Crossref
E. Sieswerda, L.C.M. Kremer, H.N. Caron & E.C. van Dalen. (2011) The use of liposomal anthracycline analogues for childhood malignancies: A systematic review. European Journal of Cancer 47:13, pages 2000-2008.
Crossref
Crossref
Yake Xue, Xiaoxing Tang, Jin Huang, Xuzhu Zhang, Jiahui Yu, Yazhuo Zhang & Songbai Gui. (2011) Anti-tumor efficacy of polymer–platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice. Colloids and Surfaces B: Biointerfaces 85:2, pages 280-288.
Crossref
Crossref
Anil Kumar Shukla, Sanjukta Patra & Vikash Kumar Dubey. (2011) Evaluation of selected antitumor agents as subversive substrate and potential inhibitor of trypanothione reductase: an alternative approach for chemotherapy of Leishmaniasis. Molecular and Cellular Biochemistry 352:1-2, pages 261-270.
Crossref
Crossref
Chiara Falciani, Antonella Accardo, Jlenia Brunetti, Diego Tesauro, Barbara Lelli, Alessandro Pini, Luisa Bracci & Giancarlo Morelli. (2011) Target‐Selective Drug Delivery through Liposomes Labeled with Oligobranched Neurotensin Peptides. ChemMedChem 6:4, pages 678-685.
Crossref
Crossref
Christian Sergelius, Shou Yamaguchi, Tetsuya Yamamoto, J. Peter Slotte & Shigeo Katsumura. (2011) N-cholesteryl sphingomyelin—A synthetic sphingolipid with unique membrane properties. Biochimica et Biophysica Acta (BBA) - Biomembranes 1808:4, pages 1054-1062.
Crossref
Crossref
Maik Hadorn & Peter Eggenberger Hotz. 2011. Biomedical Engineering Systems and Technologies. Biomedical Engineering Systems and Technologies
141
151
.
Ashay Jain, Abhinav Agarwal, Saikat Majumder, Narendra Lariya, Anil Khaya, Himanshu Agrawal, Subrata Majumdar & Govind P. Agrawal. (2010) Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug. Journal of Controlled Release 148:3, pages 359-367.
Crossref
Crossref
Lidan Xiao, Zhaoyin Hu, Wei Zhang, Chengxiong Wu, Hui Yu & Ping Wang. (2010) Evaluation of doxorubicin toxicity on cardiomyocytes using a dual functional extracellular biochip. Biosensors and Bioelectronics 26:4, pages 1493-1499.
Crossref
Crossref
Hee Seung Kim & Irving W. Wainer. (2010) Simultaneous analysis of liposomal doxorubicin and doxorubicin using capillary electrophoresis and laser induced fluorescence. Journal of Pharmaceutical and Biomedical Analysis 52:3, pages 372-376.
Crossref
Crossref
Huining He, Weibing Dong, Junbo Gong, Jingkang Wang & Victor C. Yang. (2010) Developing macromolecular therapeutics: the future drug-of-choice. Frontiers of Chemical Engineering in China 4:1, pages 10-17.
Crossref
Crossref
Atsuko Hioki, Ai Wakasugi, Kumi Kawano, Yoshiyuki Hattori & Yoshie Maitani. (2010) Development of an in Vitro Drug Release Assay of PEGylated Liposome Using Bovine Serum Albumin and High Temperature. Biological and Pharmaceutical Bulletin 33:9, pages 1466-1470.
Crossref
Crossref
Lorenzo Livi, Icro Meattini, Carla De Luca Cardillo, Monica Mangoni, Daniela Greto, Alessia Petrucci, Andrea Rampini, Alessio Bruni, Alessandra Galardi, Luigi Cataliotti & Giampaolo Biti. (2018) Non-Pegylated Liposomal Doxorubicin in Combination with Cyclophosphamide or Docetaxel as First-Line Therapy in Metastatic Breast Cancer: A Retrospective Analysis. Tumori Journal 95:4, pages 422-426.
Crossref
Crossref
Maik Hadorn, Bo Burla & Peter Eggenberger Hotz. 2009. Artificial Life: Borrowing from Biology. Artificial Life: Borrowing from Biology
126
135
.
Paola Poletti, Anna Cecilia Bettini, Elena Rota Caremoli, Roberto Labianca & Carlo Tondini. (2018) Liposomal-Encapsulated Doxorubicin (Myocet™; D-99) and Vinorelbine in Previously Treated Metastatic Breast Cancer Patients: A Feasibility Study. Tumori Journal 94:5, pages 686-690.
Crossref
Crossref
Mauro Ferrari. (2018) Nanoncology. Tumori Journal 94:2, pages 197-199.
Crossref
Crossref
Luigi Rigacci, Silvia Mappa, Luca Nassi, Renato Alterini, Valentina Carrai, Franco Bernardi & Alberto Bosi. (2007) Liposome‐encapsulated doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab in patients with lymphoma and concurrent cardiac diseases or pre‐treated with anthracyclines. Hematological Oncology 25:4, pages 198-203.
Crossref
Crossref
M. Nakayama, J.E. Chung, T. Miyazaki, M. Yokoyama, K. Sakai & T. Okano. (2007) Thermal modulation of intracellular drug distribution using thermoresponsive polymeric micelles. Reactive and Functional Polymers 67:11, pages 1398-1407.
Crossref
Crossref
Tamar Safra. (2007) Chemotherapeutics and cardiac toxicity: treatment considerations and management strategies. Community Oncology 4:9, pages 540-548.
Crossref
Crossref
Xiaobin B. Zhao, Natarajan Muthusamy, John C. Byrd & Robert J. Lee. (2007) Cholesterol as a bilayer anchor for PEGylation and targeting ligand in folate‐receptor‐targeted liposomes. Journal of Pharmaceutical Sciences 96:9, pages 2424-2435.
Crossref
Crossref
V. Lorusso, L. Manzione & N. Silvestris. (2007) Role of liposomal anthracyclines in breast cancer. Annals of Oncology 18, pages vi70-vi73.
Crossref
Crossref
Jun Wu, Xiaobin Zhao & Robert Lee. 2007. Nanoparticulate Drug Delivery Systems. Nanoparticulate Drug Delivery Systems
89
98
.
S. Dean Allison. (2007) Liposomal Drug Delivery. Journal of Infusion Nursing 30:2, pages 89-95.
Crossref
Crossref
Dawn N WaterhouseMarcel B Bally. (2006) Temporal targeting in cancer: combined chemotherapy and antiangiogenic therapy. Nanomedicine 1:3, pages 359-363.
Crossref
Crossref
Masamichi Nakayama, Teruo Okano, Takanari Miyazaki, Fukashi Kohori, Kiyotaka Sakai & Masayuki Yokoyama. (2006) Molecular design of biodegradable polymeric micelles for temperature-responsive drug release. Journal of Controlled Release 115:1, pages 46-56.
Crossref
Crossref
Jubo Liu, Helen Lee, Mario Huesca, Aiping Young & Christine Allen. (2005) Liposome formulation of a novel hydrophobic aryl-imidazole compound for anti-cancer therapy. Cancer Chemotherapy and Pharmacology 58:3, pages 306-318.
Crossref
Crossref
Michela Pisani, Paolo Bruni, Giulio Caracciolo, Ruggero Caminiti & Oriano Francescangeli. (2006) Structure and Phase Behavior of Self-Assembled DPPC−DNA−Metal Cation Complexes. The Journal of Physical Chemistry B 110:26, pages 13203-13211.
Crossref
Crossref
P. Bruni, M. Pisani, A. Amici, C. Marchini, M. Montani & O. Francescangeli. (2006) Self-assembled ternary complexes of neutral liposomes, deoxyribonucleic acid, and bivalent metal cations. Promising vectors for gene transfer?. Applied Physics Letters 88:7.
Crossref
Crossref
Willem J. M. Mulder, Gustav J. Strijkers, Geralda A. F. van Tilborg, Arjan W. Griffioen & Klaas Nicolay. (2006) Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR in Biomedicine 19:1, pages 142-164.
Crossref
Crossref
M. Nakayama & T. Okano. (2006) Intelligent thermoresponsive polymeric micelles for targeted drug delivery. Journal of Drug Delivery Science and Technology 16:1, pages 35-44.
Crossref
Crossref
Marek Langner & Arkadiusz Kozubek. 2006. Nanocarrier Technologies. Nanocarrier Technologies
113
138
.
Karlijn A. Wouters, Leontien C. M. Kremer, Tracie L. Miller, Eugene H. Herman & Steven E. Lipshultz. (2005) Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies. British Journal of Haematology 131:5, pages 561-578.
Crossref
Crossref
Robert Jan Veldman, Gerben A. Koning, Albert van Hell, Shuraila Zerp, Stefan R. Vink, Gert Storm, Marcel Verheij & Wim J. van Blitterswijk. (2005)
Coformulated
N
-Octanoyl-glucosylceramide Improves Cellular Delivery and Cytotoxicity of Liposomal Doxorubicin
. Journal of Pharmacology and Experimental Therapeutics 315:2, pages 704-710.
Crossref
Crossref
Dawn N. Waterhouse, Thomas D. Madden, Pieter R. Cullis, Marcel B. Bally, Lawrence D. Mayer & Murray S. Webb. 2005. Liposomes. Liposomes
40
57
.
Michael S. Ewer, Francis J. Martin, I. Craig Henderson, Charles L. Shapiro, Robert S. Benjamin & Alberto A. Gabizon. (2004) Cardiac safety of liposomal anthracyclines. Seminars in Oncology 31, pages 161-181.
Crossref
Crossref
Maria Laura Immordino, Paola Brusa, Flavio Rocco, Silvia Arpicco, Maurizio Ceruti & Luigi Cattel. (2004) Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs. Journal of Controlled Release 100:3, pages 331-346.
Crossref
Crossref
Qing Chen, Sheng Tong, Mark W. Dewhirst & Fan Yuan. (2004) Targeting tumor microvessels using doxorubicin encapsulated in a novel thermosensitive liposome. Molecular Cancer Therapeutics 3:10, pages 1311-1317.
Crossref
Crossref
Maria Theodoulou & Clifford Hudis. (2004) Cardiac profiles of liposomal anthracyclines. Cancer 100:10, pages 2052-2063.
Crossref
Crossref
Luigi Cattel, Maurizio Ceruti & Franco Dosio. (2018) From Conventional to Stealth Liposomes a new Frontier in Cancer Chemotherapy. Tumori Journal 89:3, pages 237-249.
Crossref
Crossref
Christine E. Swenson, Lois E. Bolcsak, Gerald Batist, Troy H. GuthrieJrJr, Katherine H. Tkaczuk, Harold Boxenbaum, Lauri Welles, Shein-Chung Chow, Rupinder Bhamra & Philip Chaikin. (2003) Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer. Anti-Cancer Drugs 14:3, pages 239-246.
Crossref
Crossref
Gretchen L Oshop, S Elankumaran, Vikram N Vakharia & Robert A Heckert. (2003) In ovo delivery of DNA to the avian embryo. Vaccine 21:11-12, pages 1275-1281.
Crossref
Crossref
Claudia Langebrake, Dirk Reinhardt & J??rg Ritter. (2002) Minimising the Long-Term Adverse Effects of Childhood Leukaemia Therapy. Drug Safety 25:15, pages 1057-1077.
Crossref
Crossref
Michael A Gosselin & Robert J Lee. 2002.
103
131
.
Fukashi Kohori, Masayuki Yokoyama, Kiyotaka Sakai & Teruo Okano. (2002) Process design for efficient and controlled drug incorporation into polymeric micelle carrier systems. Journal of Controlled Release 78:1-3, pages 155-163.
Crossref
Crossref
Alexander A. Yaroslavov, Oleg Yu. Udalykh, Nickolay S. Melik-Nubarov, Viktor A. Kabanov, Yuri A. Ermakov, Vladimir A. Azov & Fredric M. Menger. (2001) Conventional and Gemini Surfactants Embedded within Bilayer Membranes: Contrasting Behavior. Chemistry - A European Journal 7:22, pages 4835-4843.
Crossref
Crossref
M. Marty. (2001) Liposomal doxorubicin (Myocet™) and conventional anthracyclines: a comparison. The Breast 10, pages 28-33.
Crossref
Crossref
G. Batist. (2001) Improving the therapeutic index when using Myocet™ in the treatment of metastatic breast cancer. The Breast 10, pages 16-21.
Crossref
Crossref
Gerald BatistGopal RamakrishnanChandra Sekhar RaoAruna ChandrasekharanJohn GutheilTroy GuthriePankaj ShahAli KhojastehMadhavan Krishnan NairKaren HoelzerKatherine TkaczukYoun Choi ParkLily W. Lee. (2001) Reduced Cardiotoxicity and Preserved Antitumor Efficacy of Liposome-Encapsulated Doxorubicin and Cyclophosphamide Compared With Conventional Doxorubicin and Cyclophosphamide in a Randomized, Multicenter Trial of Metastatic Breast Cancer. Journal of Clinical Oncology 19:5, pages 1444-1454.
Crossref
Crossref
Dawn N. Waterhouse, Paul G. Tardi, Lawrence D. Mayer & Marcel B. Bally. (2001) A Comparison of Liposomal Formulations of Doxorubicin with Drug Administered in Free Form. Drug Safety 24:12, pages 903-920.
Crossref
Crossref
Austin L Bailey & Sean M Sullivan. (2000) Efficient encapsulation of DNA plasmids in small neutral liposomes induced by ethanol and calcium. Biochimica et Biophysica Acta (BBA) - Biomembranes 1468:1-2, pages 239-252.
Crossref
Crossref
Roger H. Bisby, Carole Mead & Christopher G. Morgan. (2007) Active Uptake of Drugs into Photosensitive Liposomes and Rapid Release on UV Photolysis ¶. Photochemistry and Photobiology 72:1, pages 57-61.
Crossref
Crossref
Roger H. Bisby, Carole Mead & Christopher G. Morgan. (2000) Active Uptake of Drugs into Photosensitive Liposomes and Rapid Release on UV Photolysis¶. Photochemistry and Photobiology 72:1, pages 57.
Crossref
Crossref
Jetske M.Meerum Terwogt, Jan H.M. Schellens, Wim W.ten Bokkel Huinink & Jos H. Beijnen. (1999) Clinical pharmacology of anticancer agents in relation to formulations and administration routes. Cancer Treatment Reviews 25:2, pages 83-102.
Crossref
Crossref
Murray S. Webb, Sandra K. Klimuk, Sean C. Semple & Michael J. Hope. 1999. Manual of Antisense Methodology. Manual of Antisense Methodology
167
190
.
Masayuki Yokoyama, Ayumi Satoh, Yasuhisa Sakurai, Teruo Okano, Yasuhiro Matsumura, Tadao Kakizoe & Kazunori Kataoka. (1998) Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. Journal of Controlled Release 55:2-3, pages 219-229.
Crossref
Crossref
CLAY SMITH, SCOTT LILLY & G. DIEGO MIRALLES. (1998)
Minireview
: Treatment of HIV Infection with Cytoreductive Agents
. AIDS Research and Human Retroviruses 14:15, pages 1305-1313.
Crossref
Crossref
Fukashi Kohori, Kiyotaka Sakai, Takao Aoyagi, Masayuki Yokoyama, Yasuhisa Sakurai & Teruo Okano. (1998) Preparation and characterization of thermally responsive block copolymer micelles comprising poly(N-isopropylacrylamide-b-dl-lactide). Journal of Controlled Release 55:1, pages 87-98.
Crossref
Crossref
Laurence Clary, Véronique Ravily, Catherine Santaella & Pierre Vierling. (1998) Transmembrane pH-driven Na+ permeability of fluorinated phospholipid-based membranes. Journal of Controlled Release 51:2-3, pages 259-267.
Crossref
Crossref
Murray S. WebbNancy L. BomanDavid J. WisemanDawn SaxonKym SuttonKim F. Wong, Patricia LoganMichael J. Hope. (1998)
Antibacterial Efficacy against an In Vivo
Salmonella typhimurium
Infection Model and Pharmacokinetics of a Liposomal Ciprofloxacin Formulation
. Antimicrobial Agents and Chemotherapy 42:1, pages 45-52.
Crossref
Crossref
CHRISTINE E. SWENSON, JEFFREY FREITAG & ANDREW S. JANOFF. 1998. Medical Applications of Liposomes. Medical Applications of Liposomes
689
702
.
Eric Mayhew, Imran Ahmad, Suresh Bhatia, Richard Dause, Julius Filep, Andrew S Janoff, Elizabet Kaisheva, Walter R Perkins, Yan Zha & J.Craig Franklin. (1997) Stability of association of 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine with liposomes is composition dependent. Biochimica et Biophysica Acta (BBA) - Biomembranes 1329:1, pages 139-148.
Crossref
Crossref
Scott A. Walker, Michael T. Kennedy & Joseph A. Zasadzinski. (1997) Encapsulation of bilayer vesicles by self-assembly. Nature 387:6628, pages 61-64.
Crossref
Crossref